Skip to content
Blinatumomab & Ponatinib for ALL episode artwork

Oct 15, 2026 15 min

Blinatumomab & Ponatinib for ALL

from OncoPharm Hosted by John Bossaer

This week we discuss the recent RCT of blinatumomab-ponatinib in Ph+ Adult ALL and how this regimen compares to previously publishes uses of Blin-Ponatinib in induction treatment. Link: DOI: 10.1056/NEJMoa2606208 Finally, we discuss two recent expanded indications in bladder cancer (nogapendekin alfa inbakicept + BCG) and colon cancer (atezolizumab with FOLFOX for dMMR colon cancer in the adjuvant setting). Download the Learning Oncology Companion: https://www.kelleycpharmd.com/learning-oncology-companion-oncopharm

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Blinatumomab & Ponatinib for ALL

0:00 15:31

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 15 minutes long.

When was this OncoPharm episode published?

This episode was published on October 15, 2026.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.